http://www.remedirx.com/newsroom/ RemediRx News en-us 2/5/2012 2:46:52 PM http://www.remedirx.com/newsroom/newsdetails.aspx.aspx?id=30 BALTIMORE, Aug. 31, 2011 /PRNewswire/ -- Baltimore-based Remedi SeniorCare , one of the nation's largest institutional pharmacy companies, today announced it has closed a $300 million equity commitment from affiliates of New York-based Centerbridge Partners, L.P., of which $60 million was funded today. The investment will support the continued growth of Remedi's customer-driven innovations, Paxit and My Remedi , as well as acquisitions and greenfield start-up pharmacies in new markets across the United States. Remedi's founding investor, Sterling Partners, will continue to participate in the company's ongoing growth. Through the development and deployment of innovative technologies and web-based solutions, Remedi enables long-term care facility operators and providers to efficiently deliver optimal medication management and unequalled resident safety and accuracy while also significantly reducing drug costs. Enabled by the success of its proprietary Paxit Automated Medication Administration System and My Remedi Web Portal in concert with its RapidResponse(SM) customer service offering, Remedi has successfully demonstrated the next generation of service capabilities in the long-term care pharmacy industry. Since deploying Paxit in August 2009, Remedi has dispensed more than 22 million individually blistered medication doses to residents in skilled nursing and assisted living facilities. This investment represents a significant milestone for Remedi, and with it comes validation of our technology-enabled service offering, its game-changing abilities and the resulting extraordinary growth potential, said Michael Bronfein, Remedi's Chairman and CEO. We have a clear vision for dramatically improving pharmacy services for our nation's seniors and will do so by significantly expanding our operating footprint and offering our leading edge innovative technology and RapidResponse customer service to more customers in more locations across the United States. There is an imminent need for innovative solutions to address our country's healthcare quality and skyrocketing costs, said Steven Silver, Centerbridge Partners' Senior Managing Director. Paxit is a proven solution that is transformational as it relates to the safety, efficiency and cost of medication. We have the utmost confidence in the Remedi team and their vision, and are eager to participate in Remedi's growth. Remedi's executive team is comprised of industry veterans with a deep understanding of this healthcare segment. The team is resolute about providing innovative, world-class customer-focused pharmacy services and solutions that address multiple issues within healthcare today, Silver added. This investment gives Remedi the strength to transform the way long-term care facilities manage medication administration for their residents, Eric Becker, Sterling Partners' Senior Managing Director. By working with providers in new markets across the country, Remedi is implementing new technologies and services that create efficiencies and cost-savings, further validating Remedi's stated goal of enabling their customer's success. We believe Remedi has the potential to change the long-term care industry as we know it. Remedi was advised by Robert W. Baird Co. (exclusive financial advisor), DLA Piper LLP (legal counsel) and Ober|Kaler (regulatory counsel). Centerbridge Partners was advised by Simpson Thacher Bartlett LLP (legal counsel) and Greenberg Traurig LLP (regulatory counsel). Sterling Partners was advised by Katten Muchin Rosenman LLP (legal counsel). About Remedi SeniorCare Remedi SeniorCare , an innovative long-term care pharmacy provider, enables long-term care facilities to deliver better business results and provide exceptional resident-centered care. At the forefront of implementing high-tech advancements for the industry, Remedi redefined medication administration and management with the launch of the Paxit automated medication dispensing system delivering superior accuracy, efficiency and medication cost reduction. Remedi's online and electronic tools via My Remedi web portal and Electronic Order Entry further drive business management efficiency and overall cost reduction. Remedi supports nearly 25,000 residents across eight states with RapidResponse(SM) customer service, ensuring prompt access to medication delivery, expertise and comprehensive support. For more information and to learn about Remedi's pharmacy services, visit www.RemediRx.com . About Centerbridge Partners, L.P. Centerbridge Partners, L.P. is a private investment firm based in New York City and currently has approximately $17 billion in capital under management. The firm focuses on private equity and credit investments. The firm is dedicated to partnering with world-class management teams across targeted industry sectors to help companies achieve their operating and financial objectives. About Sterling Partners Sterling Partners, the sponsoring investor in Remedi SeniorCare , is a leading private equity firm with more than 25 years of experience partnering with entrepreneurs to build market-leading businesses and generate superior returns. With approximately $4 billion of assets under management, Sterling invests growth capital in industries with positive, long-term trends and provides ongoing support to management through a dedicated team of industry veterans, operators, strategy experts and human capital professionals. Sterling Partners is a leader in education, healthcare and business services, with offices in Chicago, Baltimore, and Miami. For more information, please visit http://www.sterlingpartners.com/ . RemediRx News http://www.remedirx.com/newsroom/newsdetails.aspx?id=30 8/31/2011 http://www.remedirx.com/newsroom/newsdetails.aspx.aspx?id=29 Media Contact: Nicole Atkinson/Marion Janic 410-616-8947/ (212) 223-4017 natkinson@hillmanpr.com/mjanic@rooneyco.com Remedi SeniorCare Names Robert Kerr SVP of Information Systems Baltimore, Md., July 20, 2011 Remedi SeniorCare, one of the nation s largest institutional pharmacy companies, has appointed healthcare IT veteran Robert Kerr as its new senior vice president of information systems. In his new position, Kerr will be responsible for all IT functions in the business and will lead the development of My Remedi , an easy-to-use, 24/7/365 web-based portal that features an array of information and administrative tools for customers utilizing cloud computing. A seasoned executive with more than 20 years of experience working in healthcare IT, Kerr has been a trusted advisor to the most senior leaders and CEOs for whom he s worked. His career experience includes nearly 15 years in the long-term care (LTC) sector, building IT organizations for LTC companies themselves and LTC pharmacy providers. Rob brings a wealth of knowledge in the full spectrum of information technology delivery, said Michael Bronfein, Remedi s chairman and CEO. His detailed understanding of capability as well as resource requirements for technical solutions in addition to his strong technical and business communication skills will serve us well as we realize our growth potential through our My Remedi and Paxit technology offerings. Previously, Kerr was the vice president of Corporate Systems for Coram, Inc., a $500 million pharmacy company subsequently acquired by Apria Healthcare, Inc., the largest provider of HME, oxygen and home infusion therapy, where, after the company s acquisition he became the vice president of information management. Kerr also held leadership positions at OmniCare Inc., NeighborCare, Inc., Genesis Healthcare Inc., Health Objects Corporation, Integrated Health Services, Inc. and VIPS, Inc. About Remedi SeniorCare Remedi SeniorCare , a leading-edge pharmacy provider, enables long-term care facilities to deliver better business results and provide exceptional resident-centered care. At the forefront of implementing high-tech advancements for the industry, Remedi redefined medication administration and management with the launch of the Paxit automated medication dispensing system delivering superior accuracy, efficiency and medication cost reduction. Remedi's online and electronic tools via MyRemedi web portal and Electronic Order Entry further drive business management efficiency and overall cost reduction. Remedi supports nearly 25,000 residents across eight states with RapidResponse customer service, ensuring prompt, 24/7 access to medication, expertise, delivery and comprehensive support. For more information, visit www.RemediRX.com . ### RemediRx News http://www.remedirx.com/newsroom/newsdetails.aspx?id=29 7/20/2011 http://www.remedirx.com/newsroom/newsdetails.aspx.aspx?id=28 Remedi SeniorCare Expands Distribution of the Paxit Med-Pass Solution, the New Standard in Medication Administration Groundbreaking Automated Technology Defines a New Standard in Medication Accuracy, Enhances Nursing Efficiency and Provides Financial Savings for Skilled Nursing Facilities BALTIMORE, March 10, 2011 Remedi SeniorCare , which is among the nation s largest independent institutional pharmacies, is revolutionizing the long-term care (LTC) pharmacy industry with the Paxit med-pass system, its 24-hour unit dose medication administration system enabled by fully automated centralized proprietary dispensing technology. Remedi is continuing to expand its existing operations in Maryland and the Washington, D.C. area, where its robotic systems have industrialized medication administration, transforming the way personnel in skilled care facilities manage and deliver medications to their residents. The company is planning further deployment of the innovative Paxit systems in Virginia, Michigan and Ohio later in 2011. Paxit delivers a 24-hour unit-dose cycle of individually blistered medications in compliance packaging, making it the industry's most accurate medication administration system, dramatically reducing errors and medication waste while increasing nurse efficiency up to 30 percent. In addition, Paxit users can save 7 to 15 percent on overall medication costs, significantly improving the operating efficiencies within the LTC market. Since its launch in August 2009, Paxit has dispensed more than 12 million doses in 4 million Paxit bags. Currently, the system services more than 5,000 residents in Maryland, Delaware, DC and Northern Virginia. The long-term care pharmacy industry has been devoid of significant innovation for decades, said Michael Bronfein, CEO of Remedi SeniorCare. As part of Remedi s commitment to enabling its customers success, we have made the significant investment to develop this groundbreaking system, which we believe defines the new standard in medication accuracy, unparalleled patient safety and cost savings. Paxit is an industry game-changer and the answer to improving nursing satisfaction and efficiency and reducing medication costs throughout the entire system. The patent-pending Paxit technology is the result of more than five years and millions of dollars in research and development that enables its customers to achieve the benefits sought in the Patient Protection and Affordable Care Act. Benefits sought include 7-day or shorter fills for prescriptions, commonly referred to as short-cycle dispensing, ultimately leading to reduced waste associated with typical 30-day fills. Without the need for additional government regulation, Paxit exceeds the requirement of the Act by providing automated daily dose dispensing, eliminating the waste associated with many LTC facilities. Saves Nurses Time. By using Paxit, nurses on average reduce their medication administration time by 25 to 30 percent with greater accuracy and improved care. Nurses save hours a month on administrative work by eliminating the time associated with returns and refill processing. Increases accuracy. D ispensed by patent-pending advanced automation technology, medications are checked multiple times and are traceable to the pill level. Because Paxit reduces variability, nurses enjoy a far easier and safer medication administration system. Significantly Reduces Medication Costs. Paxit reduces the amount of on-hand drug inventory from 30 days to 2 days. It provides more flexibility as residents' medications change, and enables environmentally responsible business practices by dramatically reducing medication waste in long-term care. Paxit can save users 7 to 15 percent per month on their drug costs depending on resident acuity. Nurse involvement at every stage of development of Paxit resulted in a user-friendly design and smooth process flow: Easy tear-open bags and pop-out blisters with rounded corners to protect fingers; Easy-to-read bags with large print for identifying the most important information; alphabetical order of medications in the same order as the Medication Administration Record (MAR); complete administration information including date, time, room and both brand and generic drug names; HIPAA compliance with ability to separate resident name from medication information on the bag. Paxit is the first and only medication administration system designed by nurses with resident safety, nursing efficiency and cost reduction as their primary objectives. About Remedi SeniorCare Remedi SeniorCare, a leading long-term care pharmacy, transforms the way long-term care organizations manage and deliver medications for their residents. Remedi SeniorCare brings a unique understanding of the needs of long-term care nurses and administrators. The company provides reliable and accurate pharmacy delivery, innovative technology, deep expertise and high-touch service to guide facilities through the complex landscape of pharmaceutical care. Currently serving eight states and more than 22,000 residents, Remedi SeniorCare helps long-term care facilities achieve outstanding care, medication safety, operational efficiencies and Healthier Results . For more information, please visit www.RemediRX.com . About Sterling Partners Sterling Partners, the lead investor in Remedi SeniorCare, is a leading private equity firm with over 25 years of experience partnering with entrepreneurs to build market-leading businesses and generate superior returns. With approximately $4 billion of assets under management, Sterling invests growth capital in industries with positive, long-term trends and provides ongoing support to management through a dedicated team of industry veterans, operators, strategy experts and human capital professionals. Sterling Partners is a leader in education, healthcare and business services and is co-headquartered in Chicago and Baltimore. For more information, please visit www.SterlingPartners.com . ### RemediRx News http://www.remedirx.com/newsroom/newsdetails.aspx?id=28 3/10/2011 http://www.remedirx.com/newsroom/newsdetails.aspx.aspx?id=27 Baltimore, Md. (December 15, 2010) Cambridge Healthcare Management, LLC, based in Richmond, Virginia, has selected Remedi SeniorCare to provide pharmacy and consulting services to approximately 570 residents in three long-term care facilities it manages in eastern Virginia. Remedi will provide comprehensive pharmacy solutions including daily medication and supply delivery, cost management and billing support, pharmacist consulting and 24/7 clinical support to Cambridge s skilled facilities. They will be serviced by Remedi s Baltimore, Maryland and Richmond, Virginia, pharmacy locations. Woodbine Rehabilitation Healthcare and Westmoreland Rehabilitation Healthcare will be among the first facilities in northern Virginia to use Remedi s groundbreaking med-pass solution, Paxit . The solution delivers a 24-hour unit-dose cycle of individually blistered medications in compliance packaging the same way nurses deliver them to patients. Additionally, Cambridge will be utilizing Remedi s on-line portal, My Remedi , to access real time information for operational, clinical and financial data enabling better decision making in all areas of their operations to improve resident care. Cambridge s objective is to operate the long-term facilities of choice in Alexandria, Richmond and the Northern Neck of Virginia by providing excellence in healthcare says Graham Adelman, Chief Executive Officer for Cambridge Healthcare Management. We chose Remedi not only for its solid track record of service and experience in our industry, but also because of Remedi s innovative technology Paxit as well as information technology solutions that will assist us in caring for our residents. www.cambridgehealth-care.com We are extremely pleased and honored to be chosen by Cambridge, an organization with years of experience serving Virginia with resident centered care and clinical excellence, says Michael Bronfein, Chairman and CEO of Remedi SeniorCare. The fact that Cambridge has a strategic focus on innovation and best practices to advance healthcare for its long-term care residents provides for a perfect partnership between our organizations, as we collaborate to improve medication safety and the quality of life for Cambridge residents. About Remedi SeniorCare Remedi Senior Care, a long-term care pharmacy, transforms the way long-term care organizations manage and deliver medications for their residents. Growing from two established long-term care pharmacy operations, Remedi Senior Care brings a unique understanding of the needs of long-term care nurses and administrators. The company provides reliable and accurate pharmacy delivery, innovative technology, deep expertise and high-touch service to guide facilities through the complex landscape of pharmaceutical care. Currently operating four pharmacies serving eight states and 22,000 residents, Remedi SeniorCare helps long-term care facilities achieve outstanding care, medication safety and Healthier Results. www.remedirx.com About Sterling Partners Sterling Partners, the leading investor in Remedi SeniorCare, is a leading private equity firm with over 25 years of experience partnering with entrepreneurs to build market-leading businesses and generate superior returns. With approximately $4 billion of assets under management, Sterling invests growth capital in industries with positive, long-term trends and provides ongoing support to management through a dedicated team of industry veterans, operators, strategy experts and human capital professionals. Sterling Partners is a leader in education, healthcare and business services and is co-headquartered in Chicago and Baltimore. For more information, please visit www.sterlingpartners.com . RemediRx News http://www.remedirx.com/newsroom/newsdetails.aspx?id=27 12/15/2010 http://www.remedirx.com/newsroom/newsdetails.aspx.aspx?id=26 Using the redesigned site, long-term care administrators and directors of nursing can more easily access and learn about Remedi s solutions designed to help long-term care facilities achieve healthier results lower costs and improved financial strength, improved accuracy, and truly outstanding care. In a constant effort to enable our customer s success, Remedi SeniorCare combines technological innovation with excellence in everyday service to bring a uniquely comprehensive offering to the long-term care industry, says Michael Bronfein, chairman and CEO. As a leader in the industry driving innovation and service quality, our new website represents an evolution of the Remedi business model and more importantly our focus on the future. The site features testimonials from current Remedi customers, as well as a video demonstration of how Remedi s industry-leading Paxit Med-Pass Solution is helping long-term care nurses save 30 minutes per med-pass and achieve unparalleled accuracy. Current Remedi customers can also use www.RemediRx.com to access My Remedi, their one-stop Web customer portal featuring a real-time drug utilization dashboard; real-time financial and clinical alerts; electronic refills with bar-code label scanning; real-time order management; Automatic Therapeutic Interchange (ATI), Remedi s proprietary formulary management system; and much more. About Remedi SeniorCare Remedi SeniorCare, a long-term care pharmacy, transforms the way long-term care organizations manage and deliver medications for their residents. Growing from two established long-term care pharmacy operations, Remedi SeniorCare brings a unique understanding of the needs of long-term care nurses and administrators. The company provides reliable and accurate pharmacy delivery, innovative technology, deep expertise and high-touch service to guide facilities through the complex landscape of pharmaceutical care. Currently operating four pharmacies serving eight states and 22,000 residents, Remedi SeniorCare helps long-term care facilities advance outstanding care, medication safety and financial strength. www.remedirx.com About Sterling Partners Sterling Partners, the leading investor in Remedi SeniorCare, is a leading private equity firm with over 25 years of experience partnering with entrepreneurs to build market-leading businesses and generate superior returns. With approximately $4 billion of assets under management, Sterling invests growth capital in industries with positive, long-term trends and provides ongoing support to management through a dedicated team of industry veterans, operators, strategy experts and human capital professionals. Sterling Partners is a leader in education, healthcare and business services and is co-headquartered in Chicago and Baltimore. For more information, please visit www.sterlingpartners.com RemediRx News http://www.remedirx.com/newsroom/newsdetails.aspx?id=26 6/16/2010 http://www.remedirx.com/newsroom/newsdetails.aspx.aspx?id=25 Baltimore, Md. (May 21, 2010) Remedi SeniorCare, which ranks among the nation s ten largest long-term care pharmacies, today announced the appointment of Robert A. Smith, RPh, as the company s executive vice president and chief operating officer. Smith replaces Michael Mahon, who is departing after four years in the role. In this new role, Smith will oversee the day-to-day operations of the company s four long-term care pharmacies in Baltimore, Maryland, Covington, Ohio, Richmond, Virginia and Marshall, Michigan. He will be responsible for managing the customer experience with Remedi s distribution, technology and pharmacist consulting solutions. We are extremely fortunate to bring Bob Smith s strong leadership and operating experience to Remedi SeniorCare, said Michael Bronfein, chairman and CEO. His proven track record of operating performance in the long-term care pharmacy setting will be incredibly valuable as our company continues to grow our customer base and expand our geographic locations. Smith previously served as president and COO of NeighborCare, where he was instrumental in scaling the long-term care pharmacy business from $800 million to $1.2 billion through strategic initiatives. Following NeighborCare s acquisition by OmniCare in 2005, he was appointed senior vice president of operations and managed six of Omnicare s operating regions. Since 2007 he has worked as a consultant providing expertise on long-term care pharmacy and other areas of healthcare to Wall Street firms. Smith, who resides in Stevenson, Md with his wife, Jackie and daughter, Jordan is a registered pharmacist and holds a B.S. in Pharmacy from Duquesne University. About Remedi SeniorCare Remedi SeniorCare, a long-term care pharmacy, transforms the way long-term care organizations manage and deliver medications for their residents. Growing from two established long-term care pharmacy operations, Remedi SeniorCare brings a unique understanding of the needs of long-term care nurses and administrators. The company provides reliable and accurate pharmacy delivery, innovative technology, deep expertise and high-touch service to guide facilities through the complex landscape of pharmaceutical care. Currently operating four pharmacies serving eight states and 22,000 residents, Remedi SeniorCare helps long-term care facilities advance outstanding care, medication safety and financial strength. www.remedirx.com About Sterling Partners Sterling Partners, the leading investor in Remedi SeniorCare, is a leading private equity firm with over 25 years of experience partnering with entrepreneurs to build market-leading businesses and generate superior returns. With approximately $4 billion of assets under management, Sterling invests growth capital in industries with positive, long-term trends and provides ongoing support to management through a dedicated team of industry veterans, operators, strategy experts and human capital professionals. Sterling Partners is a leader in education, healthcare and business services and is co-headquartered in Chicago and Baltimore. For more information, please visit www.sterlingpartners.com. RemediRx News http://www.remedirx.com/newsroom/newsdetails.aspx?id=25 5/21/2010 http://www.remedirx.com/newsroom/newsdetails.aspx.aspx?id=13 Baltimore, Md. (PRWEB) March 18, 2010 -- Remedi SeniorCare, the nation s seventh largest long-term care pharmacy, today announced the appointment of Kathleen Chagnon as general counsel. In her new role, Chagnon will lead all legal, regulatory and compliance affairs for Remedi SeniorCare. I am extremely pleased to have someone of Kathleen s caliber lead our legal and compliance initiatives and guide Remedi SeniorCare as our business grows and evolves, says Michael Bronfein, Chief Executive Officer and Chairman of the Board. Kathleen is a highly regarded legal executive with deep experience and knowledge in corporate and transactional law and regulatory compliance. Her leadership will enable Remedi SeniorCare to expertly navigate a rapidly changing regulatory environment and manage legal and compliance risk for our company and our customers. Chagnon previously held senior positions in Fortune 150 companies, including serving as Vice President, Deputy General Counsel and Chief Compliance Officer for American International Group (AIG), Senior Vice President, General Counsel and Chief Compliance Officer of Constellation Energy Group and Vice President and Corporate Group General Counsel of The St. Paul Companies Inc. In addition to her corporate background, she has extensive private practice experience, including as a partner at DLA Piper LLP and Saul Ewing LLP, and as an associate at Hogan Hartson and O Melveny Myers. Throughout her career, Chagnon s legal practice has included international trade, corporate compliance and risk management, corporate governance and corporate transactional work. A classical music enthusiast, Chagnon has served on the board of the Baltimore Symphony Orchestra since 2004 and currently provides corporate governance and legal guidance as an executive officer and corporate secretary of the organization. She previously served as a board member of the St. Paul Chamber Orchestra in St. Paul, Minn. Chagnon received her J.D. from Columbia University Law School with a concentration in international law and a bachelor of arts from Stanford University with Honors. About Remedi SeniorCare Remedi SeniorCare, a long-term care pharmacy, transforms the way long-term care organizations manage and deliver medications for their residents. Growing from two established long-term care pharmacy operations, Remedi SeniorCare brings a unique understanding of the needs of long-term care nurses and administrators. The company provides reliable and accurate pharmacy delivery, innovative technology, deep expertise and high-touch service to guide facilities through the complex landscape of pharmaceutical care. Currently operating four pharmacies serving eight states and over 22,000 residents, Remedi SeniorCare helps long-term care facilities advance outstanding care, medication safety and financial strength. www.remedirx.com About Sterling Partners Sterling Partners, the sponsoring investor in Remedi SeniorCare is a leading private equity firm with over 25 years of experience partnering with entrepreneurs to build market-leading businesses and generate superior returns. With approximately $4 billion of assets under management, Sterling invests growth capital in industries with positive, long-term trends and provides ongoing support to management through a dedicated team of industry veterans, operators, strategy experts and human capital professionals. Sterling Partners is a leader in education, healthcare and business services and is co-headquartered in Chicago and Baltimore. For more information, please visit www.sterlingpartners.com . RemediRx News http://www.remedirx.com/newsroom/newsdetails.aspx?id=13 3/18/2010 http://www.remedirx.com/newsroom/newsdetails.aspx.aspx?id=14 Baltimore, Md. (February 3, 2009) Remedi SeniorCare has expanded its presence in the Michigan and Ohio long-term care marketplace with the addition of two new customers for its comprehensive pharmacy services. Vista Grande Villa of Jackson, Michigan, and The Laurels in Blanchester, Ohio, have selected Remedi SeniorCare as their long-term care pharmacy of record. Remedi will provide the two facilities with daily deliveries of medications and supplies, cost management and billing support, pharmacist consulting and 24/7 clinical support. Founded in 1970, Vista Grande Villa is a retirement community providing long-term, skilled nursing care as part of a full continuum of healthcare and lifestyle options for seniors. The 60-bed facility began receiving services from Remedi on Friday, January 15, 2010, and is being serviced by Remedi s Marshall, Michigan pharmacy. Remedi has been an excellent pharmacy partner with our four communities in Maryland, so when we had a need in Michigan, they were the first call, says Andi Putnam, Business Development Manager with Care Purchasing Services, Inc., the purchasing division for Life Care Services, Inc. We especially appreciate how Remedi combines great service with real-time technology. We depend heavily on our Web customer portal, My Remedi, to obtain important information from the pharmacy throughout the day. We are thrilled to be supporting Vista Grande Villa, a unique lifecare facility for lower Michigan residents, says Karla Roberts, RPh, Remedi s Michigan general manager. With this expanded relationship, Remedi can provide Vista Grande Villa with innovative solutions to support their progressive, compassionate approach to senior care. It is a perfect match. The Laurels of Blanchester provides professional care for short- and long-term residents with the highest level of independence, dignity and quality of life. The 50-bed facility started being serviced by Remedi s Covington, Ohio, pharmacy on Monday, February 1, 2010. The Laurels is a staple of its community, and is focused on providing comfort, care and peace of mind to its residents and families, says Don Groff, RPh, Remedi s Ohio general manager. As The Laurels long-term care pharmacy partner, we can take much of the labor-intensive administrative and cost management work out of the staff s hands and let them focus on caring for their residents. We re excited about a prosperous partnership. About Remedi SeniorCare Remedi SeniorCare, a long-term care pharmacy, transforms the way long-term care organizations manage and deliver medications for their residents. Growing from two established long-term care pharmacy operations, Remedi SeniorCare brings a unique understanding of the needs of long-term care nurses and administrators. The company provides reliable and accurate pharmacy delivery, innovative technology, deep expertise and high-touch service to guide facilities through the complex landscape of pharmaceutical care. Currently operating four pharmacies serving eight states and over 22,000 residents, Remedi SeniorCare helps long-term care facilities advance outstanding care, medication safety and financial strength. www.remedirx.com About Sterling Partners Sterling Partners, the sponsoring investor in Remedi SeniorCare is a leading private equity firm with over 25 years of experience partnering with entrepreneurs to build market-leading businesses and generate superior returns. With approximately $4 billion of assets under management, Sterling invests growth capital in industries with positive, long-term trends and provides ongoing support to management through a dedicated team of industry veterans, operators, strategy experts and human capital professionals. Sterling Partners is a leader in education, healthcare and business services and is co-headquartered in Chicago and Baltimore. For more information, please visit www.sterlingpartners.com. RemediRx News http://www.remedirx.com/newsroom/newsdetails.aspx?id=14 2/4/2010 http://www.remedirx.com/newsroom/newsdetails.aspx.aspx?id=15 Baltimore, Md. (January 12, 2010) A Remedi SeniorCare long-term care pharmacy representative will provide in-depth information about important regulatory changes impacting Virginia nursing homes and assisted living facilities at the Virginia Health Care Association (VHCA) Pharmacy Update being held today in Richmond, Va. Larry Kelley, R.Ph., senior relationship manager for Remedi and an experienced long-term care pharmacist, will update attendees on key changes to the Drug Enforcement Administration s (DEA) policies regarding the prescribing, delivery and handling of Schedule II controlled substances (CII). Kelley s presentation will cover the complete list of essential information and processes, delivered as step-by-step checklists for administrators and nurses. There continue to be changes in how the DEA is enforcing the handling of controlled substances in long-term care, says Kelley. This update will help members of Virginia s long-term care community fully understand what everyone in the process prescribers, pharmacies and nurses have to do to remain compliant with DEA regulations. Kelley presents alongside two fellow pharmacists Hill Hopper, R.Ph., of Omnicare Inc., and Jeff Schneider, R.Ph., of Legacy Consultant Pharmacy to give attendees a full picture of the numerous changes going into effect this month for long-term care facilities in Virginia. The pharmacists, who collaborate frequently on educational programs for the long-term care community, will also discuss recent changes to regulations regarding STAT boxes and floor stocks of over-the-counter medications in facilities. A 39-year veteran of long-term care pharmacy, Kelley stays actively involved in state trade associations and works closely with state Boards of Pharmacy and legislative bodies to lobby for positive change for long-term care. His regular participation in events such as the VHCA Pharmacy Update exemplifies Remedi s commitment to the long-term care community. Some long-term care pharmacies have no involvement in their industry outside of being a vendor to their customers, says Kelley. From its inception, all the way back to its early roots, Remedi has always been deeply involved, not just as a vendor but in all areas of long-term care to make customers successful. We actively lend our voice and expertise to contribute to the success of our entire industry. About Remedi SeniorCare Remedi SeniorCare, a long-term care pharmacy, transforms the way long-term care organizations manage and deliver medications for their residents. Growing from two established long-term care pharmacy operations, Remedi SeniorCare brings a unique understanding of the needs of long-term care nurses and administrators. The company provides reliable and accurate pharmacy delivery, innovative technology, deep expertise and high-touch service to guide facilities through the complex landscape of pharmaceutical care. Currently operating four pharmacies serving eight states and over 22,000 residents, Remedi SeniorCare helps long-term care facilities advance outstanding care, medication safety and financial strength. www.remedirx.com About Sterling Partners Sterling Partners, the sponsoring investor in Remedi SeniorCare is a leading private equity firm with over 25 years of experience partnering with entrepreneurs to build market-leading businesses and generate superior returns. With approximately $4 billion of assets under management, Sterling invests growth capital in industries with positive, long-term trends and provides ongoing support to management through a dedicated team of industry veterans, operators, strategy experts and human capital professionals. Sterling Partners is a leader in education, healthcare and business services and is co-headquartered in Chicago and Baltimore. For more information, please visit www.sterlingpartners.com. RemediRx News http://www.remedirx.com/newsroom/newsdetails.aspx?id=15 1/12/2010 http://www.remedirx.com/newsroom/newsdetails.aspx.aspx?id=16 Baltimore, Md. (October 28, 2009) Effectively immediately, Michael Bronfein has assumed the role of Chief Executive Officer for long-term care pharmacy Remedi SeniorCare. He retains his existing role as Chairman of the Board for the company, which he has held since co-founding the company in 2005. The organizational change helps to position Remedi SeniorCare for large-scale growth. Currently the country s seventh largest institutional pharmacy, Remedi is poised to expand its comprehensive pharmacy solutions into new geographical areas across the U.S. over the next two to three years. In his new role, Bronfein will focus on the company s strategic vision and growth acceleration in target markets. Prior to his role at Remedi, Bronfein founded and spent 10 years as Senior Managing Director at private equity firm Sterling Partners, where he led healthcare investing activities. He was also was Co-founder, Chairman, President and CEO of NeighborCare, which he helped grow from a single retail pharmacy to a national leader in long-term care and managed care pharmacy services, serving more than 250,000 long-term care residents and achieving revenues of more than $1 billion. We are beginning a new chapter in Remedi SeniorCare s business, says Bronfein. We ve grown dramatically in four short years, based on our deep experience, our strong customer relationships and our exceptional people. With our new organizational structure, we have the strength to transform our business and change pharmacy forever for our customers. About Remedi SeniorCare Remedi SeniorCare, a long-term care pharmacy, transforms the way long-term care organizations manage and deliver medications for their residents. Growing from two established long-term care pharmacy operations, Remedi SeniorCare brings a unique understanding of the needs of long-term care nurses and administrators. The company provides reliable and accurate pharmacy delivery, innovative technology, deep expertise and high-touch service to guide facilities through the complex landscape of pharmaceutical care. Currently operating four pharmacies serving eight states and over 22,000 residents, Remedi SeniorCare helps long-term care facilities advance outstanding care, medication safety and financial strength. www.remedirx.com About Sterling Partners Sterling Partners, the sponsoring investor in Remedi SeniorCare is a leading private equity firm with over 25 years of experience partnering with entrepreneurs to build market-leading businesses and generate superior returns. With approximately $4 billion of assets under management, Sterling invests growth capital in industries with positive, long-term trends and provides ongoing support to management through a dedicated team of industry veterans, operators, strategy experts and human capital professionals. Sterling Partners is a leader in education, healthcare and business services and is co-headquartered in Chicago and Baltimore. For more information, please visit www.sterlingpartners.com. RemediRx News http://www.remedirx.com/newsroom/newsdetails.aspx?id=16 10/28/2009 http://www.remedirx.com/newsroom/newsdetails.aspx.aspx?id=17 Remedi Senior Care transforms the way long-term care organizations manage and deliver medications for their residents. Growing from two established long-term care pharmacy operations, including Woodhaven Pharmacy in Baltimore, Md., and HealthCare Pharmacy in Covington, Ohio, Remedi Senior Care brings a unique understanding of the needs of long-term care nurses and administrators. The company provides reliable and accurate pharmacy delivery, innovative technology, deep expertise and high-touch service to guide facilities through the complex landscape of pharmaceutical care. Based in Baltimore, Remedi SeniorCare currently serves more than 22,000 residents and helps long-term care facilities advance outstanding care, medication safety and financial strength. About Remedi SeniorCare Remedi SeniorCare, a long-term care pharmacy, transforms the way long-term care organizations manage and deliver medications for their residents. Growing from two established long-term care pharmacy operations, Remedi SeniorCare brings a unique understanding of the needs of long-term care nurses and administrators. The company provides reliable and accurate pharmacy delivery, innovative technology, deep expertise and high-touch service to guide facilities through the complex landscape of pharmaceutical care. Currently operating four pharmacies serving eight states and over 22,000 residents, Remedi SeniorCare helps long-term care facilities advance outstanding care, medication safety and financial strength. www.remedirx.com About Sterling Partners Sterling Partners, the sponsoring investor in Remedi SeniorCare is a leading private equity firm with over 25 years of experience partnering with entrepreneurs to build market-leading businesses and generate superior returns. With approximately $4 billion of assets under management, Sterling invests growth capital in industries with positive, long-term trends and provides ongoing support to management through a dedicated team of industry veterans, operators, strategy experts and human capital professionals. Sterling Partners is a leader in education, healthcare and business services and is co-headquartered in Chicago and Baltimore. For more information, please visit www.sterlingpartners.com. RemediRx News http://www.remedirx.com/newsroom/newsdetails.aspx?id=17 10/26/2009 http://www.remedirx.com/newsroom/newsdetails.aspx.aspx?id=18 Baltimore, Md. (October 1, 2009) Remedi SeniorCare, the seventh largest long-term care pharmacy in the United States, announces will host its annual the Remedi SeniorCare Annual Education Conference October 21, 2009, at the Conference Center at the Maritime Institute in Linthicum Heights, Md. This year s conference theme is Leading by Example. The conference provides attendees with a full day of workshops delving into the latest issues and best practices in long-term care. Led by clinical experts with inside knowledge of long-term care processes and procedures, the day s sessions provide insight and guidance on topics including pain management, eMAR and QIS preparation. Ongoing education is essential for long-term care organizations to stay ahead of changing dynamics and deliver high-quality, resident-focused care, says Jen Hardesty, PharmD, FASCP, clinical services manager for Remedi SeniorCare. Remedi s Annual Education Conference provides a day of practical education as well as hands-on demonstrations of the industry s latest technology. Schedule of Events 7:30 Registration Opens 8:15 Opening Remarks Michael Mahon, COO, Remedi SeniorCare 8:30 Pain Is Inevitable, but Suffering is Not David Johns, RPh, FASCP, dhjRxConsulting, LLC 9:30 Break and Exhibits Open 10:00 Hot Topics in Long-Term Care Fred Evans, RPh, Drug Inspector, Division of Drug Control Danna Kauffman, Vice President of Public Policy, LifeSpan Jen Hardesty, PharmD, FASCP, Clinical Services Manager, Remedi SeniorCare 11:15 Lunch and Exhibits Open Remedi eMAR Demo Available at 12:15 1:00 QIS Bootcamp! William Vaughan, RN, BSN, Chief Nurse, Office of Health Care Quality Lee Ann Wheatley, RN, QA Surveyor, Office of Health Care Quality 2:15 Closing Remarks and Raffle 2:30 Remedi New Medication Packaging Demo Registration costs $15 per attendee and is open to all long-term care administrators and nurses. About Remedi SeniorCare Remedi Senior Care, a long-term care pharmacy, transforms the way long-term care organizations manage and deliver medications for their residents. Growing from two established long-term care pharmacy operations, Remedi Senior Care brings a unique understanding of the needs of long-term care nurses and administrators. The company provides reliable and accurate pharmacy delivery, innovative technology, deep expertise and high-touch service to guide facilities through the complex landscape of pharmaceutical care. Currently operating four pharmacies serving eight states and 22,000 residents, Remedi SeniorCare helps long-term care facilities advance outstanding care, medication safety and financial strength. www.remedirx.com About Sterling Partners Sterling Partners, the leading investor in Remedi SeniorCare, is a leading private equity firm with over 25 years of experience partnering with entrepreneurs to build market-leading businesses and generate superior returns. With approximately $4 billion of assets under management, Sterling invests growth capital in industries with positive, long-term trends and provides ongoing support to management through a dedicated team of industry veterans, operators, strategy experts and human capital professionals. Sterling Partners is a leader in education, healthcare and business services and is co-headquartered in Chicago and Baltimore. For more information, please visit www.sterlingpartners.com. RemediRx News http://www.remedirx.com/newsroom/newsdetails.aspx?id=18 10/1/2009 http://www.remedirx.com/newsroom/newsdetails.aspx.aspx?id=19 Richmond, VA, and Marshall, MI (September 14, 2009) - Remedi SeniorCare, a premier provider of pharmacy services for long-term care facilities, has opened two new pharmacies in Richmond, VA, and Marshall, MI. The Richmond facility will service Virginia-based long-term care facilities statewide with every day delivery of medications and supplies and local account management. The Marshall facility will service long-term care facilities on the lower peninsula of Michigan, northern Ohio and northern Indiana. The brand new, state-of-the-art institutional pharmacy facilities are two of four Remedi SeniorCare pharmacies serving the Mid-Atlantic and Midwest regions. To learn more or to schedule a tour of the Virginia or Michigan pharmacy, please contact Remedi SeniorCare at 1-800-232-4239. About Remedi SeniorCare Remedi SeniorCare, a long-term care pharmacy, transforms the way long-term care organizations manage and deliver medications for their residents. Growing from two established long-term care pharmacy operations, Remedi SeniorCare brings a unique understanding of the needs of long-term care nurses and administrators. The company provides reliable and accurate pharmacy delivery, innovative technology, deep expertise and high-touch service to guide facilities through the complex landscape of pharmaceutical care. Currently operating four pharmacies serving eight states and over 22,000 residents, Remedi SeniorCare helps long-term care facilities advance outstanding care, medication safety and financial strength. www.remedirx.com RemediRx News http://www.remedirx.com/newsroom/newsdetails.aspx?id=19 9/14/2009 http://www.remedirx.com/newsroom/newsdetails.aspx.aspx?id=20 Baltimore, Md. (July 15, 2008) Remedi SeniorCare, a premier provider of pharmacy services for senior healthcare facilities, announced today that it has completed the acquisition of HealthCare Pharmacy of Covington, Ohio. Remedi SeniorCare, formerly Woodhaven Health Services, will now serve more than 20,000 residents in Maryland, Delaware, Washington D.C., Virginia, Ohio, Kentucky, Indiana and Michigan, placing it among the nation s top 10 independent institutional pharmacies. Remedi President and CEO Michael Mahon welcomed HealthCare Pharmacy s employees and customers to Remedi SeniorCare, emphasizing Remedi s commitment to providing personalized, hands-on service and intelligent pharmacy technologies. We re building on Remedi s successful track record to help more senior healthcare facilities achieve healthier results for their residents, said Mahon. The acquisition is part of our controlled-growth strategy to be a multi-regional provider of institutional pharmacy solutions. HCP CEO Jay Meyer expressed the importance of finding a strong business partner that shares HealthCare Pharmacy s culture of providing high-quality pharmacy services to residents of senior healthcare facilities. We found that Remedi SeniorCare offers an excellent combination of customer-focused service, a strong market presence, and the advanced technologies that HCP needs to better serve our customers, said Meyer. Meyer will become President and Chief Operating Officer of Midwest operations for Remedi SeniorCare. No other staffing changes are planned. We re very fortunate to have Jay Meyer join our team, said Mahon. Jay has built an organization that shares the values and philosophy that have made Remedi SeniorCare a premier pharmacy services provider. He and the Ohio team will continue to provide customers in the region with hands-on account management, as well as My Remedi, our comprehensive suite of web-based medication management tools. All Remedi SeniorCare customers will gain access to My Remedi, which provides an integrated e-pharmacy experience that simplifies drug dispensing and documentation, and offers real-time tracking of prescription drug usage and costs. About Remedi SeniorCare Remedi SeniorCare, a long-term care pharmacy, transforms the way long-term care organizations manage and deliver medications for their residents. Growing from two established long-term care pharmacy operations, Remedi SeniorCare brings a unique understanding of the needs of long-term care nurses and administrators. The company provides reliable and accurate pharmacy delivery, innovative technology, deep expertise and high-touch service to guide facilities through the complex landscape of pharmaceutical care. Currently operating four pharmacies serving eight states and over 22,000 residents, Remedi SeniorCare helps long-term care facilities advance outstanding care, medication safety and financial strength. www.remedirx.com RemediRx News http://www.remedirx.com/newsroom/newsdetails.aspx?id=20 7/15/2008 http://www.remedirx.com/newsroom/newsdetails.aspx.aspx?id=21 Baltimore, Md. (May 5, 2008) Woodhaven Health Services, a premier provider of pharmacy services for senior healthcare facilities, announced today that it is changing its name to Remedi SeniorCare. The new name, and accompanying new logo, kicks off a long-term strategic plan to position the company as a multi-regional provider of comprehensive pharmacy services for senior care facilities and the residents they serve. President and CEO Michael Mahon rang in the new name and unveiled the new logo with employees last Friday, stressing the company s commitment to both its customers and employees. Mahon stated that Remedi SeniorCare will continue to provide the same exceptional level of service its customers have come to associate with Woodhaven, with the added benefit of a new, comprehensive suite of web-based pharmacy management technologies called My Remedi. The new name more accurately reflects our company s unique combination of quality driven service, hands-on account management and intelligent pharmacy technologies, said Mahon. We re building on Woodhaven s successful track record to help more senior healthcare facilities achieve healthier results for their residents. As we position our company for the future, we must always remember our roots as an organization that delivers care from one person to another. The name change occurs simultaneously with the introduction of My Remedi, a comprehensive suite of web-based medication management tools. My Remedi, which will begin its roll-out in June 2008, provides facilities with an integrated e-pharmacy experience that will simplify drug dispensing and documentation, as well as provide real-time tracking of prescription drug usage and costs. About Remedi SeniorCare Remedi SeniorCare, a long-term care pharmacy, transforms the way long-term care organizations manage and deliver medications for their residents. Growing from two established long-term care pharmacy operations, Remedi SeniorCare brings a unique understanding of the needs of long-term care nurses and administrators. The company provides reliable and accurate pharmacy delivery, innovative technology, deep expertise and high-touch service to guide facilities through the complex landscape of pharmaceutical care. Currently operating four pharmacies serving eight states and over 22,000 residents, Remedi SeniorCare helps long-term care facilities advance outstanding care, medication safety and financial strength. www.remedirx.com RemediRx News http://www.remedirx.com/newsroom/newsdetails.aspx?id=21 5/5/2008